Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Solventum (SOLV)

April 6, 2026 5:57 AM
BTIG analyst Ryan Zimmerman reiterated a Buy rating and $100.00 price target on Solventum (NYSE: SOLV).The analyst comments "We wanted ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments